Using smart devices to improve healing of diabetic foot ulcers
Improving the science of adherence reinforcement and safe mobility in people with diabetic foot ulcers using smart offloading
This study is testing a new smart device that helps people with diabetic foot ulcers heal better by reminding them to use it correctly, and it’s comparing how well this device works compared to regular treatment methods.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11012795 on NIH RePORTER |
What this research studies
This research focuses on enhancing the healing process for patients with diabetic foot ulcers by utilizing a smart offloading device called MOTUS Smart. This device allows for real-time monitoring of patient adherence to prescribed offloading therapy, which is crucial for healing. Patients will receive notifications on their smartwatches if they are not using the device correctly, helping to reinforce adherence. The study aims to compare the effectiveness of this innovative approach against traditional methods to determine its impact on healing and mobility.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neuropathic diabetic foot ulcers who require offloading therapy.
Not a fit: Patients who do not have diabetic foot ulcers or those who are unable to use smart technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve healing rates for diabetic foot ulcers, reducing the risk of complications such as amputation.
How similar studies have performed: Previous research has shown promise in using technology to enhance patient adherence in various medical treatments, suggesting potential success for this novel approach.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Armstrong, David George — University of Southern California
- Study coordinator: Armstrong, David George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.